153 related articles for article (PubMed ID: 23849401)
21. Visual diagnosis: a small bowel obstruction.
Siddiqua T; Easley D; Thomas S; Zenel JA; Pohl JF
Pediatr Rev; 2009 Dec; 30(12):486-90. PubMed ID: 19952130
[No Abstract] [Full Text] [Related]
22. Crohn's disease diagnosis during adalimumab treatment.
Fernández Salazar L; Barrio Andrés J; González Hernández JM
Scand J Gastroenterol; 2013 Feb; 48(2):254-5. PubMed ID: 23061423
[TBL] [Abstract][Full Text] [Related]
23. Adalimumab induction for Crohn's disease.
Cottone M; Mocciaro F; Scimeca D
Gastroenterology; 2006 May; 130(6):1929. PubMed ID: 16697762
[No Abstract] [Full Text] [Related]
24. [Update on current care guidelines. Care of Crohn's Disease].
Niemelä S; Jussila A; Järvinen H; Jäättelä A; Karvonen AL; Rasmussen M; Ruuska T
Duodecim; 2005; 121(17):1851-2. PubMed ID: 16262123
[No Abstract] [Full Text] [Related]
25. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
[TBL] [Abstract][Full Text] [Related]
26. Crohn's disease management after intestinal resection: a randomised trial.
De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Gibson PR; Sparrow M; Leong RW; Florin TH; Gearry RB; Radford-Smith G; Macrae FA; Debinski H; Selby W; Kronborg I; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
Lancet; 2015 Apr; 385(9976):1406-17. PubMed ID: 25542620
[TBL] [Abstract][Full Text] [Related]
27. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
[TBL] [Abstract][Full Text] [Related]
28. Giant sigmoid diverticulum: a rare complication of a common disease.
Marín MR; Candel Arenas MF; Parra Baños PA; González Valverde FM; Garaulet ET; Tamayo Rodríguez ME; Faraco MR; Ros EP; Marín-Blázquez AA
Am Surg; 2011 Jan; 77(1):115-6. PubMed ID: 21396321
[No Abstract] [Full Text] [Related]
29. Violaceous plaque on the nose referred for rhinophyma surgery.
Gupta-Elera G; Lam C; Chung C; Billingsley EM
Int J Dermatol; 2015 Sep; 54(9):1011-3. PubMed ID: 26148121
[No Abstract] [Full Text] [Related]
30. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Valenzuela C; Cisneros C; Gisbert JP
World J Gastroenterol; 2015 Feb; 21(7):2260-2. PubMed ID: 25717268
[TBL] [Abstract][Full Text] [Related]
31. [Crohn's disease].
;
Duodecim; 2005; 121(10):1112-30. PubMed ID: 15999515
[No Abstract] [Full Text] [Related]
32. Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease.
Eder P; Lykowska-Szuber L; Krela-Kazmierczak I; Stawczyk-Eder K; Linke K
Acta Gastroenterol Belg; 2013 Mar; 76(1):74-5. PubMed ID: 23650791
[No Abstract] [Full Text] [Related]
33. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
34. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Fortea-Ormaechea JI; González-Lama Y; Casis B; Chaparro M; López Serrano P; Van Domselaar M; Bermejo F; Pajares R; Ponferrada A; Vera MI; Martínez Montiel P; Gisbert JP; Pérez-Calle JL; López San Román A; Abreu L; Menchén LA; Marín-Jiménez I
Gastroenterol Hepatol; 2011; 34(7):443-8. PubMed ID: 21724297
[TBL] [Abstract][Full Text] [Related]
35. A practical, evidence-based guide to the use of adalimumab in Crohn's disease.
Rubin DT; Panaccione R; Chao J; Robinson AM
Curr Med Res Opin; 2011 Sep; 27(9):1803-13. PubMed ID: 21809894
[TBL] [Abstract][Full Text] [Related]
36. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
Baert F; Glorieus E; Reenaers C; D'Haens G; Peeters H; Franchimont D; Dewit O; Caenepeel P; Louis E; Van Assche G;
J Crohns Colitis; 2013 Mar; 7(2):154-60. PubMed ID: 22537637
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination.
Fraison JB; Guilpain P; Schiffmann A; Veyrac M; Le Moing V; Rispail P; Le Quellec A
J Crohns Colitis; 2013 Feb; 7(1):e11-4. PubMed ID: 22647638
[TBL] [Abstract][Full Text] [Related]
38. Capsule enteroscopy and Crohn's disease.
Maiden L; Bjarnason I
Clin Gastroenterol Hepatol; 2006 May; 4(5):660; author reply 660-1. PubMed ID: 16678078
[No Abstract] [Full Text] [Related]
39. Cutaneous granulomatous vasculitis in metastatic Crohn's disease.
Sabat M; Leulmo J; Saez A
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):652-3. PubMed ID: 16164737
[No Abstract] [Full Text] [Related]
40. Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres.
Mandel MD; Balint A; Golovics PA; Vegh Z; Mohas A; Szilagyi B; Szabo A; Kurti Z; Kiss LS; Lovasz BD; Gecse KB; Farkas K; Molnar T; Lakatos PL
Dig Liver Dis; 2014 Nov; 46(11):985-90. PubMed ID: 25156871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
